HK1204341A1 - Aptamer-based multiplexed assays - Google Patents
Aptamer-based multiplexed assaysInfo
- Publication number
- HK1204341A1 HK1204341A1 HK15104829.2A HK15104829A HK1204341A1 HK 1204341 A1 HK1204341 A1 HK 1204341A1 HK 15104829 A HK15104829 A HK 15104829A HK 1204341 A1 HK1204341 A1 HK 1204341A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aptamer
- multiplexed assays
- based multiplexed
- assays
- multiplexed
- Prior art date
Links
- 108091023037 Aptamer Proteins 0.000 title 1
- 238000003556 assay Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/205—Aptamer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656956P | 2012-06-07 | 2012-06-07 | |
PCT/US2013/044792 WO2013185078A1 (en) | 2012-06-07 | 2013-06-07 | Aptamer-based multiplexed assays |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204341A1 true HK1204341A1 (en) | 2015-11-13 |
Family
ID=49712701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104829.2A HK1204341A1 (en) | 2012-06-07 | 2015-05-20 | Aptamer-based multiplexed assays |
Country Status (22)
Country | Link |
---|---|
US (4) | US20150141259A1 (es) |
EP (1) | EP2859121B1 (es) |
JP (1) | JP6298456B2 (es) |
KR (1) | KR102088381B1 (es) |
CN (2) | CN108614102A (es) |
AU (1) | AU2013271401B2 (es) |
BR (1) | BR112014030298B1 (es) |
CA (1) | CA2873099C (es) |
CY (1) | CY1118748T1 (es) |
ES (1) | ES2617226T3 (es) |
HK (1) | HK1204341A1 (es) |
HR (1) | HRP20170296T1 (es) |
IL (1) | IL235588B (es) |
IN (1) | IN2014KN02647A (es) |
MX (1) | MX356413B (es) |
MY (1) | MY170164A (es) |
NZ (1) | NZ701824A (es) |
PH (1) | PH12014502581A1 (es) |
RU (1) | RU2666989C2 (es) |
SG (2) | SG11201407505XA (es) |
WO (1) | WO2013185078A1 (es) |
ZA (1) | ZA201408409B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
US8975026B2 (en) | 2007-01-16 | 2015-03-10 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
WO2015109020A1 (en) * | 2014-01-14 | 2015-07-23 | Aptitude Medical Systems, Inc. | Use of nucleic acid agents for ultra-sensitive digital detection and quantification of target molecules |
WO2015126769A1 (en) * | 2014-02-18 | 2015-08-27 | Somalogic, Inc. | Compositions and methods for detecting microorganisms |
WO2015179848A1 (en) * | 2014-05-23 | 2015-11-26 | Firefly Bioworks, Inc. | Substrate-mediated reactors for bioassays |
GB2528643A (en) * | 2014-07-08 | 2016-02-03 | Adc Biotechnology Ltd | Method of synthesising ADCs |
KR102003589B1 (ko) * | 2016-03-03 | 2019-07-24 | 성균관대학교산학협력단 | 생화학 분자 검출센서 및 다파장 형광을 이용한 생화학 분자 검출방법 |
CN105779609A (zh) * | 2016-04-15 | 2016-07-20 | 上海伊丽萨生物科技有限公司 | 一种超敏免疫检测方法 |
WO2018071813A1 (en) * | 2016-10-13 | 2018-04-19 | Laboratory Corporation Of America Holdings | Devices and methods to reduce interfering compounds in biological samples |
WO2019200307A1 (en) * | 2018-04-13 | 2019-10-17 | Fluidigm Canada Inc. | Stabilized cell acquisition for elemental analysis |
US11181501B2 (en) | 2018-09-11 | 2021-11-23 | City University Of Hong Kong | Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample |
LU101073B1 (en) * | 2018-12-21 | 2020-06-24 | Luxembourg Inst Science & Tech List | Dna aptamers specific of adenovirus types |
KR102177672B1 (ko) * | 2019-02-01 | 2020-11-12 | 주식회사 압타머사이언스 | 압타머를 이용한 다중(multiplex) PCR 방법 |
KR102113078B1 (ko) * | 2019-07-05 | 2020-05-20 | 광주과학기술원 | 압타머의 선별 방법 |
CN110791551A (zh) * | 2019-09-17 | 2020-02-14 | 北京化工大学 | 一种无载体氯霉素适配体信号放大传感器的建立方法 |
JP2023504683A (ja) * | 2019-12-03 | 2023-02-06 | キム・ソンチョン | 試料の標的分子集団に対するプロファイルを得る方法 |
CN113624724A (zh) * | 2020-05-07 | 2021-11-09 | 廖世奇 | 一种适配体分子信标对靶分子的多元检测分析方法 |
CN111812313B (zh) * | 2020-06-22 | 2021-10-08 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
WO2022232308A1 (en) | 2021-04-27 | 2022-11-03 | Singular Genomics Systems, Inc. | High density sequencing and multiplexed priming |
KR20220167781A (ko) * | 2021-06-14 | 2022-12-21 | 김성천 | 압타머를 이용하여 시료의 표적 단백질 분자 집단에 대한 프로파일을 얻는 방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
PL202358B1 (pl) * | 1999-11-17 | 2009-06-30 | Roche Diagnostics Gmbh | Sposób wytwarzania kompozycji magnetycznych cząstek szklanych, magnetyczne cząstki szklane, kompozycja magnetycznych cząstek szklanych, zawiesina z magnetycznymi cząstkami szklanymi, probówka z kompozycją lub zawiesiną magnetycznych cząstek szklanych, zestaw części z tą probówką, zastosowanie kompozycji, zawiesiny i zestawu zawierających magnetyczne cząstki szklane, sposób izolowania materiału biologicznego |
US7601497B2 (en) * | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
AU2003256806A1 (en) * | 2002-07-24 | 2004-02-09 | Ciphergen Biosystems, Inc. | Protein interaction difference mapping |
ZA200610693B (en) * | 2004-05-19 | 2008-06-25 | Vp Holding Llc | Optical sensor with layered plasmon structure for enhanced detection of chemical groups by sers |
US7699979B2 (en) * | 2005-01-07 | 2010-04-20 | Board Of Trustees Of The University Of Arkansas | Separation system and efficient capture of contaminants using magnetic nanoparticles |
US7285835B2 (en) * | 2005-02-24 | 2007-10-23 | Freescale Semiconductor, Inc. | Low power magnetoelectronic device structures utilizing enhanced permeability materials |
EP1918372A4 (en) * | 2005-07-05 | 2009-08-12 | Ribomic Inc | NUCLEIC ACID CAPABLE OF BINDING TO IMMUNOGLOBULIN G AND USE THEREOF |
US20070166740A1 (en) * | 2006-01-17 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
US7855054B2 (en) * | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
US7964356B2 (en) | 2007-01-16 | 2011-06-21 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
PT2172566E (pt) * | 2007-07-17 | 2015-06-23 | Somalogic Inc | Método para gerar aptámeros com taxas de dissociação melhoradas |
US8291501B2 (en) * | 2008-02-08 | 2012-10-16 | Cheng Holdings, Llc | Validation of protected intra-system interconnects for digital rights management in electrical computers and digital data processing systems |
US20110120487A1 (en) * | 2008-05-30 | 2011-05-26 | L'oreal | Hair treatment methods and kits |
US8440801B2 (en) * | 2008-07-14 | 2013-05-14 | The University Of Tokyo | Aptamer against IL-17 and use thereof |
CA2758620C (en) * | 2009-04-13 | 2018-10-16 | Agriculture And Food Development Authority (Teagasc) | Method of producing microbeads |
GB0916700D0 (en) * | 2009-09-23 | 2009-11-04 | Nanoco Technologies Ltd | Semiconductor nanoparticle-based materials |
-
2013
- 2013-06-07 EP EP13801106.9A patent/EP2859121B1/en active Active
- 2013-06-07 CN CN201810446555.7A patent/CN108614102A/zh active Pending
- 2013-06-07 CA CA2873099A patent/CA2873099C/en active Active
- 2013-06-07 NZ NZ701824A patent/NZ701824A/en unknown
- 2013-06-07 MY MYPI2014703374A patent/MY170164A/en unknown
- 2013-06-07 JP JP2015516253A patent/JP6298456B2/ja active Active
- 2013-06-07 BR BR112014030298-7A patent/BR112014030298B1/pt active IP Right Grant
- 2013-06-07 US US14/401,791 patent/US20150141259A1/en not_active Abandoned
- 2013-06-07 ES ES13801106.9T patent/ES2617226T3/es active Active
- 2013-06-07 IN IN2647KON2014 patent/IN2014KN02647A/en unknown
- 2013-06-07 CN CN201380040107.2A patent/CN104508150B/zh active Active
- 2013-06-07 MX MX2014014784A patent/MX356413B/es active IP Right Grant
- 2013-06-07 KR KR1020147034387A patent/KR102088381B1/ko active IP Right Grant
- 2013-06-07 WO PCT/US2013/044792 patent/WO2013185078A1/en active Application Filing
- 2013-06-07 SG SG11201407505XA patent/SG11201407505XA/en unknown
- 2013-06-07 RU RU2014152698A patent/RU2666989C2/ru not_active Application Discontinuation
- 2013-06-07 SG SG10201701361WA patent/SG10201701361WA/en unknown
- 2013-06-07 AU AU2013271401A patent/AU2013271401B2/en active Active
-
2014
- 2014-11-09 IL IL235588A patent/IL235588B/en active IP Right Grant
- 2014-11-17 ZA ZA2014/08409A patent/ZA201408409B/en unknown
- 2014-11-19 PH PH12014502581A patent/PH12014502581A1/en unknown
-
2015
- 2015-05-20 HK HK15104829.2A patent/HK1204341A1/xx unknown
-
2017
- 2017-02-22 CY CY20171100249T patent/CY1118748T1/el unknown
- 2017-02-22 HR HRP20170296TT patent/HRP20170296T1/hr unknown
- 2017-03-09 US US15/454,080 patent/US20170176422A1/en not_active Abandoned
- 2017-11-30 US US15/827,441 patent/US20180224444A1/en active Pending
-
2021
- 2021-03-30 US US17/217,006 patent/US20210239692A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1204341A1 (en) | Aptamer-based multiplexed assays | |
HK1248702A1 (zh) | 取代的吡咯烷-2-甲酰胺 | |
SG11201500239VA (en) | Asymmetric auxiliary group | |
DK3327112T3 (en) | Agse-deficient stamme | |
HK1200830A1 (en) | Substituted pyrrolidine-2-carboxamides -2- | |
EP2754580A4 (en) | DUMP TRUCK | |
DK2830816T3 (en) | Hidtil ukendt coatingkoncept | |
HK1204797A1 (en) | Novel anti-siglec15 antibody -siglec-15 | |
HK1206724A1 (en) | Substituted benzothienopyrimidines | |
EP2708024A4 (en) | MULTIPLEXING MOCA-WIFI | |
HU4206U (en) | Multi purposal sportsdevice | |
EP2920142A4 (en) | MÉTHANOFULLERRÈNES | |
EP2934541A4 (en) | NORIBOGAINE SUBSTITUTE | |
HK1206022A1 (zh) | 取代的咪唑並噠嗪 | |
GB201220662D0 (en) | Assays | |
EP2873363A4 (en) | DIOPSIMETER | |
GB2500883B (en) | Improved saw-horse | |
EP2917534A4 (en) | DIVIDED INTERMEDIATE HOUSING | |
EP2834250A4 (de) | Lithiumsilikate | |
GB201201720D0 (en) | Novel combinations | |
ZA201305187B (en) | Improved brattice | |
GB201212393D0 (en) | Novel combination | |
AU345893S (en) | Treehouse | |
GB201211502D0 (en) | GoingThrice | |
GB201202208D0 (en) | Easomark |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register |
Free format text: ADDITION OF INVENTOR: OLIVAS, EDGAR |